Status:
RECRUITING
Examining Heavy Metal Exposure and Respiratory Health in Young Adult Electronic Cigarette Users
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Conditions:
Heavy Metal Exposure From Vaping
Eligibility:
All Genders
18-29 years
Brief Summary
This study investigates heavy metal exposure in young adults who use electronic cigarettes.
Detailed Description
PRIMARY OBJECTIVES: I. Identify and quantify heavy metals (HM) concentration in the saliva of e-cigarette users. II. Examine changes in pulmonary functioning and HM concentration pre/post vaping. I...
Eligibility Criteria
Inclusion
- Aged 18-29 years
- Established electronic cigarette (EC) user (participant uses ECs on a daily/weekly basis \[used on ≥ 5 days in past 30-days\] for the past 3 months)
- Willing to abstain from nicotine for at least 12 hours before the laboratory visit
- Willing to not eat food or drink water/beverages for at least 30 minutes before the laboratory visit \[required for salivary collection\]
- Utilize 4th generation EC products (pod-mod or disposable EC products; e.g., JUUL, Hyde)
- Must be able to read and write in English
Exclusion
- Recently COVID-19+ (defined as a positive test in the past 30 days) or a recent COVID-19 hospitalization (within the past 6 months)
- Attempting to quit the use of ECs
- Past 30-day use of other tobacco products (e.g., combustible cigarettes)
- Is pregnant, planning on becoming pregnant and/or breastfeeding \[will be verified using a urine pregnancy test\]
- Self-reported severe or significant psychological and/or psychiatric conditions \[e.g., not currently receiving treatment/medication; only past and/or stable conditions will be allowed\]
- A history of cardiac events and/or distress within the past 3 months
- Diagnosed with a chronic, serious lung disease or current infection (e.g., pneumonia, pulmonary edema)
- Are deaf, hard of hearing, or have a severe motor disability
Key Trial Info
Start Date :
October 22 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07215065
Start Date
October 22 2025
End Date
May 31 2026
Last Update
October 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States, 43210